Home » Newsletters » BioWorld MedTech

BioWorld MedTech

May 18, 2016

View Archived Issues

Mitralign scores $40M in series E, eyes EU launch for MPAS system

South Korea reports robust domestic med-tech sector growth in face of economic slowdown

Anthem expands IMRT coverage to treatment of entire esophagus

Other news to note

Appointments and advancements

Daily M&A

Financings

MDD's Oncology Extra

Explosive report shows TAVR heart valves degrading at 8 years

PARIS – Transcatheter aortic valve replacement (TAVR) is now considered a mature procedure. Read More

Finding Neo: Siemens Healthineers explores new waters via liquid biopsy company buy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026